4.6 Article

Identification and Roles of miR-29b-1-3p and miR29a-3p-Regulated and Non-Regulated lncRNAs in Endocrine-Sensitive and Resistant Breast Cancer Cells

Journal

CANCERS
Volume 13, Issue 14, Pages -

Publisher

MDPI
DOI: 10.3390/cancers13143530

Keywords

miR-29; lncRNA; tamoxifen; endocrine resistance; breast cancer

Categories

Funding

  1. NIH [R01 CA138410]

Ask authors/readers for more resources

Despite improvements in treating endocrine-resistant metastatic diseases using combination therapies, the mechanisms underlying endocrine resistance are still unclear. Non-coding RNAs, such as miRNA and lncRNA, have been shown to play a role in cell signaling pathways and metastasis. This study identified miR-29-regulated and differentially expressed lncRNAs in endocrine-resistant breast cancer, offering new insights into potential therapeutic targets.
Despite improvements in the treatment of endocrine-resistant metastatic disease using combination therapies in patients with estrogen receptor alpha (ER alpha) primary tumors, the mechanisms underlying endocrine resistance remain to be elucidated. Non-coding RNAs (ncRNAs), including microRNAs (miRNA) and long non-coding RNAs (lncRNA), are targets and regulators of cell signaling pathways and their exosomal transport may contribute to metastasis. Previous studies have shown that a low expression of miR-29a-3p and miR-29b-3p is associated with lower overall breast cancer survival before 150 mos. Transient, modest overexpression of miR-29b1-3p or miR-29a-3p inhibited MCF-7 tamoxifen-sensitive and LCC9 tamoxifen-resistant cell proliferation. Here, we identify miR-29b-1/a-regulated and non-regulated differentially expressed lncRNAs in MCF-7 and LCC9 cells using next-generation RNA seq. More lncRNAs were miR-29b-1/a-regulated in LCC9 cells than in MCF-7 cells, including DANCR, GAS5, DSCAM-AS1, SNHG5, and CRND. We examined the roles of miR-29-regulated and differentially expressed lncRNAs in endocrine-resistant breast cancer, including putative and proven targets and expression patterns in survival analysis using the KM Plotter and TCGA databases. This study provides new insights into lncRNAs in endocrine-resistant breast cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available